Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Bleeding issues in neonates and infants - Update 2015
Ulrike Nowak-Göttl
*
, Verena Limperger
, Alexander Bauer
, Dorothee Kowalski
,
Gili Kenet
*
Corresponding author for this work
University Medical Center Schleswig- Holstein
Sheba Medical Center at Tel Hashomer
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bleeding issues in neonates and infants - Update 2015'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Neonate
100%
Bleeding
100%
Bleeding Neonate
50%
Plasma Parameters
25%
Screening Test
25%
Healthy children
25%
Symptom Severity
25%
Physiologic
25%
Family History
25%
Treatment Options
25%
Contact Level
25%
Laboratory Abnormalities
25%
Bleeding Symptoms
25%
Complete Blood Count
25%
Thrombocytopenia
25%
FXIII
25%
Absolute Value
25%
Premature Infant
25%
Plasma Concentration
25%
Platelet Function
25%
Diagnostic Approach
25%
Treating Physicians
25%
Term Babies
25%
Bleeding Disorders
25%
Coagulation Assays
25%
Underlying Medical Conditions
25%
Laboratory Assessment
25%
Emergency Case
25%
Coagulation Proteins
25%
Vitamin K-dependent Factors
25%
Abnormal Coagulation
25%
Clinical Bleeding
25%
Developmental Hemostasis
25%
Bleeding Questionnaire
25%
α2-antiplasmin
25%
Age-related Values
25%
Contact Factor
25%
Inherited Coagulation Disorders
25%
Hemorrhage
25%
Laboratory Test Results
25%
Hemostatic Defect
25%
Reagent Mode
25%
Coagulation Screen
25%
Medicine and Dentistry
Bleeding
100%
Neonate
100%
Prematurity
16%
Family History
16%
Hemostat
16%
Blood Stasis
16%
Thrombocytopenia
16%
Laboratory Test
16%
Thrombocyte Function
16%
Blood Cell
16%
Cell Count
16%
Screening Test
16%
Bleeding Disorder
16%
Coagulopathy
16%
Laboratory Assessment
16%
Alpha 2-Antiplasmin
16%
Coagulation Screen
16%
Treatment Option
16%
Bleeding
16%